IMNN: Results from OVATION 2 Study in Mid-2024
On May 13, 2024, Imunon, Inc. (IMNN) announced financial results for the first quarter of 2024 and provided a business update. The company is on...
284 Views
𝛼SK or SearchENTITY
Imunon (IMNN US)
Imunon (IMNN US)
22
Analysis
Health Care • United States
IMUNON, Inc. operates as a clinical stage biotechnology company. The Company focuses on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON serves customers worldwide.
morex